Laboratory modalities for assessing hemostasis during cardiopulmonary bypass
- PMID: 138934
- DOI: 10.1055/s-0028-1086130
Laboratory modalities for assessing hemostasis during cardiopulmonary bypass
Abstract
This discussion has outlined several simple and reliable test systems which have been found useful in assessing disorders of hemostasis in the hemorrhaging CPB patient. When these tests are utilized as described in the preceding article, they have been extremely helpful in studying hemostasis in the CPB patient to be reexplored; they are equally helpful to quickly render a differential diagnosis of altered hemostasis when hemorrhage occurs. In addition, several "special" procedures, the AT-III and heparin assays, have been reviewed; these have been found quite useful in special instances of CPB hemorrhage, and community cardiovascular teams may wish them to be available. This paper has not presumed to be "authoritative" with respect to the "best" tests for assessing CPB hemostasis, but rather has offered only an approach helpful to the authors. The intent has, however, been to provide guidelines for instituting simple, reliable, and workable procedures for the community hospital where CPB is now routinely performed.
Similar articles
-
Alterations of hemostasis associated with cardiopulmonary bypass: pathophysiology, prevention, diagnosis, and management.Semin Thromb Hemost. 1976 Oct;3(2):59-82. doi: 10.1055/s-0028-1086129. Semin Thromb Hemost. 1976. PMID: 798278 Review.
-
Alterations of hemostasis associated with cardiopulmonary bypass.Thromb Res. 1976 Mar;8(3):285-302. doi: 10.1016/0049-3848(76)90023-2. Thromb Res. 1976. PMID: 131387 No abstract available.
-
Hemostatic defects induced by cardiopulmonary bypass.Vasc Surg. 1975 Sep-Oct;9(4):228-43. doi: 10.1177/153857447500900407. Vasc Surg. 1975. PMID: 1106031 Review. No abstract available.
-
Cardiopulmonary bypass. Associated hemostatic abnormalities.J Thorac Cardiovasc Surg. 1979 Mar;77(3):427-35. J Thorac Cardiovasc Surg. 1979. PMID: 762986 No abstract available.
-
Strategies to reduce hemostatic activation during cardiopulmonary bypass.Thromb Res. 2006;117(6):689-703. doi: 10.1016/j.thromres.2005.05.028. Epub 2005 Jul 5. Thromb Res. 2006. PMID: 15996721
Cited by
-
Soluble fibrin monomer complex and cardiopulmonary bypass.J Extra Corpor Technol. 2009 Sep;41(3):157-60. J Extra Corpor Technol. 2009. PMID: 19806798 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources